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ABSTRACT
The ability to visualize mRNA in single living cells
and monitor in real-time the changes of mRNA level
and localization can provide unprecedented oppor-
tunities for biological and disease studies. However,
the mRNA detection specificity and sensitivity are
critically dependent on the selection of target
sequences and their accessibility. We carried out
an extensive study of the target accessibility of
BMP-4 mRNA using 10 different designs of mole-
cular beacons (MBs), and identified the optimal
beacon design. Specifically, for MB design 1 and 8
(MB1 and MB8), the fluorescent intensities from
BMP-4 mRNA correlated well with the GFP signal
after upregulating BMP-4 and co-expressing GFP
using adenovirus, and the knockdown of BMP-4
mRNA using siRNA significantly reduced the beacon
signals, demonstrating detection specificity. The
beacon specificity was further confirmed using
blocking RNA and in situ hybridization. We found
that fluorescence signal from MBs depends criti-
cally on target sequences; the target sequences
corresponding to siRNA sites may not be good sites
for beacon-based mRNA detection, and vice versa.
Possible beacon design rules are identified and
approaches for enhancing target accessibility are
discussed. This has significant implications to MB
design for live cell mRNA detection.
INTRODUCTION
The ability to detect, quantify and monitor the expression
of speciﬁc genes in living cells, tissues and animals will
oﬀer unprecedented opportunities for the early detection
of disease, clinical diagnosis, prognosis and treatment
monitoring based on molecular markers of the disease.
Although in vitro assays such as DNA microarrays,
RT–PCR and northern blotting can quantify changes in
gene expression level of a cell population, they cannot be
used for in vivo detection of mRNA. On the other hand,
the use of reporter plasmids for fusion of GFP to RNA
binding proteins requires the identiﬁcation of unique
proteins for each speciﬁc mRNA; it may not reﬂect the
true expression level of the target mRNA. Signiﬁcant
challenges exist in detecting endogenous gene expression
in vivo, including probe design and in vivo delivery, speciﬁc
targeting and reporting, probe toxicity and the sensitivity
of the imaging methods (1,2). In particular, it is necessary
to design sophisticated probes in targeting intracellular
disease markers so that high detection speciﬁcity, sensi-
tivity and signal to background ratio can be achieved.
Of all candidate technologies for in vivo endogenous
mRNA detection, the most promising one is molecular
beacons (MBs) technology. MBs are dual-labeled anti-
sense oligonucleotide (ODN) probes with a ﬂuorophore at
one end and a quencher at the other end (3,4). They are
designed to form a stem–loop (hairpin) structure in the
absence of a complementary target so that ﬂuorescence of
the ﬂuorophore is quenched. Hybridization with the target
mRNA opens the hairpin and physically separates the
reporter from quencher, allowing a ﬂuorescence signal to
be emitted upon excitation. Although MBs have the
potential to detect endogenous gene expression in living
cells with high sensitivity, to realize this potential, many
probe design issues need to be carefully addressed.
To establish the live-cell endogenous mRNA detection
capability of MBs, eﬀorts have been made to increase the
signal-to-background (S/B) ratio by using dual MBs that
form a FRET pair (5,6), to increase the MB stability
by modifying the oligonucleotide probe backbone using
20-O-methyl chemistry (7–9), and to use color-shifting
MBs (10). More recently, ﬂuorescent protein complemen-
tation has also been used to increase the S/B of the live-cell
imaging assay (11,12). However, in all these MB-based
methods, a major design issue is target accessibility. It is
well known that an mRNA in a living cell has secondary
structures and binds to RNA-binding proteins to form
an RNP (ribonucleoprotein). Thus, if the target sequence
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portions of the mRNA or it is occupied by RNA-binding
proteins, the beacon has to compete oﬀ the mRNA strand
or RNA-binding protein(s) in order to hybridize to the
target. This may signiﬁcantly reduce the signal level
resulting from MBs binding to their target mRNA,
especially with DNA backbone MBs. Although MBs
with 20-O-methyl backbone have an increased aﬃnity
to target mRNAs (and an enhanced resistance to
degradation by DNase or RNase-H), thus having a
better target accessibility when competing with double-
strand RNA or RNA-binding proteins, the beacon back-
bone is RNA-like, hence upon probe/target binding
the resulting double-strand RNA may trigger RNA
interference, or other unwanted cellular response. It is
also possible that 20-O-methyl MB could interfere with
protein production (13,14).
In this work, we focused on addressing target accessi-
bility issues with DNA backbone MBs. We chose bone
morphogenic protein 4 (BMP-4, a member of the TGF-b
superfamily) as the target mRNA since BMP-4 protein
is involved in bone formation, stem cell diﬀerentiation
(15–17) and plays a key role in proatherogenic inﬂamma-
tory response and hypertension (18–21). We tested 10
diﬀerent designs of MBs to identify the optimal beacon
design, and performed both upregulation and down-
regulation of BMP-4 using, respectively, adenovirus
infection and siRNA knockdown. Co-expressing GFP
and the use of blocking RNA and in situ hybridization
further conﬁrmed the detection speciﬁcity. The results in
this study provide important insights into target accessi-
bility, and a basis for MB design rules. The ability to
monitor BMP-4 mRNA expression and localization in
living cells in real time may also provide a useful tool for
speciﬁc studies of basic biology and disease states.
MATERIALS AND METHODS
Cellculture
Normal human dermal ﬁbroblast (HDF) cells (Cambrex,
NJ, USA) were grown in Clonetics ﬁbroblast growth
medium supplemented with 2% FBS, insulin, ﬁbroblast
growth factor, gentamicin sulfate and amphotericin-B
(all from Cambrex, NJ, USA). HDF cells were used in our
MB studies due to their low auto-ﬂuorescence and ease for
probe delivery.
MB design and synthesis
Ten diﬀerent MBs (MB1-MB8, MB8a, Mb8b) targeting
mouse BMP-4 mRNA and a ‘random’-sequence MB
(‘random beacon’) were designed, synthesized and tested.
The ‘random beacon’ for negative control assays has a
speciﬁc 16-base target sequence that does not match with
any mammalian gene. All MBs were designed to have
DNA (20-deoxy) backbone labeled with Cy3 ﬂuorophore
at the 50 end and Black Hole quencher 2 (BHQ2) at the
30 end; the speciﬁc sequences of these MBs are shown in
Table 1, with the underlined sequences as stem sequences.
The corresponding target sequences of mouse BMP-4
mRNA are shown in Figure 2. As shown in Table 1, all
MBs have a stem length of 5 bases (with GC to AT ratio
of 4) and, except MB5 which has the same stem sequence
as MB3, all other beacons have diﬀerent stem sequences.
The calculated melting temperatures of MBs and MB/
target duplexes are also shown in Table 1. The MB
melting temperature was calculated using the program at:
http://frontend.bioinfo.rpi.edu/applications/mfold/cgi-bin
/dna-form1.cgi, and that of MB/target duplexes was
calculated using the Hyther Server at: http://ozone3.
chem.wayne.edu/, with 200nM concentration for beacons
and DNA target, respectively. All calculates were using
folding temperature of 378C and ionic condition of 10mM
KCl and 5mM MgCl2. All MBs were synthesized by
MWG Biotech (High Point, NC).
MB delivery and imaging experiments
MBs were delivered into live HDF cells with a reversible
permeabilization method using activated Streptolysin O
(SLO) (6). Speciﬁcally, SLO was activated ﬁrst by adding
5mM of TCEP to 2U/ml of SLO for 30min at 378C. Cells
were incubated for 10min in 250ml of serum-free medium
containing 0.1–0.2U/ml of activated SLO (0.25–0.5U
SLO per 10
6 cells) and 0.5ml (0.2mM) or 2.5ml( 1mM) of
MB for cell permeabilization and beacon delivery. Cells
were then resealed by adding 0.5ml of the typical growth
medium and incubated for 1h at 378C before performing
ﬂuorescence microscopy imaging. Each MB experiment
Table 1. The design of mouse BMP-4 and random molecular beacons and their computed melting temperature
Beacon ID Molecular Beacon Design Melting temperature (8C)
MB Duplex
MB1 50-Cy3-CCCGTTATAATAACAGTCCATACGGG-BHQ2-30 56.0 45.4
MB2 50-Cy3-CGGACTCTGTAGAAGTGTCGCCGTCCG-BHQ2-30 52.4 59.4
MB3 50-Cy3-CCCACGGAGCCGGTAAAGATGTGGG-BHQ2-30 57.6 55.8
MB4 50-CY3-CCAGCCTGCTCTTCCTCCTCCTCGCTGG-BHQ2-30 52.3 62.4
MB5 50-Cy3-CGCTCCCCGGTTCCCTGGCTCGAGCG-BHQ2-30 54.8 66.3
MB6 50-CY3-CACCCTAACGATCGGCTGATGGGTG-BHQ2-30 55.3 54.5
MB7 50-Cy3-CGCTCCCCAATCTCCACTCCGAGCG-BHQ2-30 55.7 56.6
MB8 50-Cy3-CGCAGCCTCTACCACCATCTCCCTGCG-BHQ2-30 55.4 57.5
MB8a 50-Cy3-CGAGCCCATCTCCTGATAATTTGCTCG-BHQ2-30 55.2 51.4
MB8b 50-Cy3-CCGACCACCCCTCTACCACGTCGG-BHQ2-30 55.0 55.3
Random MB 50-Cy3-CGACGCGACAAGCGCACCGATACGTCG-BHQ2-30 57.7 NA
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reproducibility.
The ﬂuorescence imaging of live cells was performed
using a Zeiss Axiovert 100 TV epiﬂuorescence microscope
coupled to a Cooke Sensicam SVGA cooled CCD camera.
Zeiss 100  and 40  EC Plan-NEOFLUAR oil objectives
with N.A. (Numerical Aperture) of 1.3 were used for the
experiments. The ﬂuorescence of Cy3-labeled beacons was
imaged with excitation at 545nm and emission detection
at 570nm, and GFP ﬂuorescence was imaged with
excitation at 470nm and emission detection at 525nm.
Same exposure times (30ms for GFP and 400 or 800ms
for Cy3) were used for the imaging experiments.
Real-time quantitative PCR
Total RNA was isolated from cells using Qiagen RNeasy
Mini Kit. 100ng of total RNA was used for cDNA
synthesis by random hexamers with Invitrogen Thermo-
script RT–PCR kit. For real-time PCR, the cDNA was
ampliﬁed using a Stratagene Mx3005P (Stratagene)
RT–PCR machine. The Ambion’s 18S primers were used
as an internal control for real-time PCR. PCR ampliﬁca-
tion was performed with the following primers with
608C as the annealing temperature: 50–TGGACTGTTA
TTATGCCTT-30 and 50-GGAGATCACCTCATTTTCT
GG-30 (22).
Adenovirus and siRNAs
To upregulate BMP-4 expression, HDF cells were infected
for 2 days with adenovirus containing both ‘mouse’ BMP-
4 and polycistronic GFP cDNAs (BMP-4 adenovirus).
GFP was used as an independent marker for infection,
but not tagged to BMP-4 protein. The BMP-4 siRNA
(contains MB6 hybridization site) (sense: 50-GUC
AGAAUCAGCCGAUCGUUACCUCAA-30, antisense:
50-UUGAGGUAACGAUCGGCUGAUUCUGAC-30)
and nonsilencing siRNA (Qiagen) were transfected with
Oligofectamine (Invitrogen) at the concentration of
100nM. Four hours after siRNA transfection, HDF
cells were infected by BMP-4 adenovirus in the growth
medium and incubated for 2 days. BMP-4 mRNA
knockdown experiments (n=4) were also performed
using siRNAs that target the hybridization sites of MB1
(siRNA-MB1) and MB8 (siRNA-MB8), respectively. The
siRNA-MB1 (sense: 50-AUGGACUGUUAUUAUAUG
CCUUGUUUU-30, antisense: 50-AAAACAAGGCAUA
UAAUAACAGUCCAU-30) and the siRNA-MB8 (sense:
50-UAUCAGGAGAUGGUGGUAGAGGGGUGU-30,
antisense: 50-ACACCCCUCUACCACCAUCUCCUGA
UA-30) were transfected and the results quantiﬁed follow-
ing the same procedure as described above for BMB-4
siRNA.
Blocking RNA experiment
To conﬁrm detection speciﬁcity, we used blocking RNAs
that can compete with MBs targeting BMP-4 mRNA,
with targeting sequences of 50-CAUAUAAUAACAGUC
CAUGA-30 (competing with MB1, see Table 1) and
50-CCCCUCUACCACCAUCUCCUG-30 (competing
with MB8, see Table 1). Two days after adenovirus
infection, these blocking RNAs were delivered into HDF
cells by SLO with diﬀerent concentrations of 0.2–40mM,
followed by 2-h incubation in normal media for recovery
and hybridization of blocking RNA to its target. BMP-4
targeting MBs were then delivered into cells at a
concentration of 100nM and the resulting ﬂuorescence
signal was imaged by epiﬂuorescence microscope 1h after
MB delivery.
Fluorescence in situ hybridization (FISH)
Normal cells and adenoviral BMP-4 infected cells were
ﬁxed with 4% paraformaldehyde for 15min at room
temperature and then permeabilized with 0.2% Triton
X-100 for 3min. Blocking was performed with 0.1%
Escherichia coli tRNAs and 1% RNase-free BSA in
2  SSC/25% formamide solution for 1h at 508C.
Formamide was added to decrease the melting tempera-
ture between the probe and mRNA. After washing three
times, cells were incubated with BMP-4-targeting FISH
probe with 20-O-methyl backbone, 50-Cy3-ACUCCCUU
GAGGUAACGAUCGGCUGAUUCUGACAUGCUG
G-30, at the concentration of 50nM in 2  SSC/25%
formamide overnight at 508C. After washing with 2 
SSC/25% formamide for three times, cells were observed
with epiﬂuorescence microscope.
RESULTS AND DISCUSSION
Target accessibility
An important issue in live-cell mRNA detection is target
accessibility. In contrast to in vitro (in solution) hybridiza-
tion of MBs with target oligonucleotides, for a MB probe
to hybridize to a target mRNA in a living cell, it has to
overcome several obstacles, including the secondary
structure of mRNAs, RNA-binding proteins and degra-
dation of the probes due to endonucleases. As illustrated
in Figure 1, the folded structure of an mRNA in a living
cell is due to both the double-stranded segments of the
mRNA and the RNA-binding proteins. If the target
sequence is buried deep in the folded structure, a beacon
has to penetrate into the folded mRNA. If the target
sequence has a double-stranded portion, a beacon needs to
compete with the RNA strand. More signiﬁcantly, since
an mRNA in a living cell always has RNA-binding
proteins on it to form an RNP, if the target sequence is
occupied by an RNA-binding protein (or proteins), the
beacon has to compete oﬀ the RNA-binding protein(s) in
order to hybridize to the target sequence. Thus, although
an MB can be designed to have its probe sequence unique
to the target mRNA, the target sequence may not be
necessarily accessible in a living cell. Furthermore,
although double-stranded portions of an mRNA can be
predicted using, for example, mFOLD, predictions of the
folded structure of an mRNA may not be accurate. More
problematically, due to the very limited available informa-
tion on RNA-binding proteins, it is not possible to
predict, at any given stage of an mRNA, what proteins
bind to it and where. Therefore, there is a lack of
guidelines on how to optimize the MB design to have
a better target RNA accessibility in a living cell.
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detection of endogenous mRNAs.
To address the target accessibility issues and to identify
possible design rules for MBs, in this work we used mouse
BMP-4 mRNA as a model system not only because of
its biological signiﬁcance in cardiovascular and cancer
studies using animal models, but also because the
availability of reagents in our group to use adenovirus
for its upregulation and siRNAs probes for its down-
regulation. We have designed eight diﬀerent BMP-4
targeting MBs to target diﬀerent sites on the BMP-4
mRNA, including siRNA-binding sites, translation initia-
tion site, FISH probe-binding sites and predicted antisense
oligonucleotide-binding sites. Speciﬁcally, as shown in
Figure 2 and Table 1, MB probe #1 (hereafter referred to
as MB1) was designed to hybridize to the site containing
the AUG translation initiation codon. This site was
selected since previous studies in antisense research have
suggested that the translation initiation site is a good site
for generating an antisense eﬀect, indicating that this
site might be accessible for the antisense oligonucleotide
probes. MB2 and MB6 were designed to hybridize
respectively to the two siRNA-binding sites that have
been eﬀectively used by our group to downregulate the
BMP-4 mRNA level. MB4 was designed based on a FISH
probe sequence that has been previously reported for the
in situ detection of BMP-4 mRNA (23). MB7 and MB8
were designed based on the sequences of antisense
oligonucleotide probes recommended by mFOLD at the
Integrate DNA Technology web site (http://www.idtdna.
com/Scitools/Applications/mFold/). MB3 and MB5 were
randomly chosen. The sequences of all eight probes
were checked with BLAST search to make sure that they
are unique to the BMP-4 mRNA.
Shown in Figure 3 are the increases of BMP-4 mRNA 1
and 2 days after adenovirus infection, quantiﬁed using
real-time PCR. Evidently, 2 days after infection, BMP-4
mRNA level increased by more than 4000-fold compared
to that of control (uninfected) cells. Thus, in the
subsequent target accessibility studies, MBs were delivered
into cells 2 days after infection and incubated for another
1h before ﬂuorescence imaging. GFP signal from the same
cells was used as an indication of the eﬀect of infection,
since the adenoviral constructs co-express GFP and mouse
BMP-4. In most cases, HDF cells without viral infection
(cells did not express mouse BMP-4 mRNA) did not show
discernible ﬂuorescence signal from MB delivery and
hybridization, indicating that, without target mRNAs in
HDF cells, MBs produced very low background signal
due to nonspeciﬁc interaction and/or degradation of
probes (data not shown).
Figure 4 shows the ﬂuorescence signal of 8 BMP-4
targeting MBs (MB1-MB8) in infected HDF cells.
Speciﬁcally, MB1 and MB8 produced intense punctate
Figure 1. A schematic illustration of a segment of the target mRNA
with a double-stranded portion and RNA-binding proteins.
A molecular beacon has to compete oﬀ an mRNA strand or
RNA-binding protein(s) in order to hybridize to the target.
Figure 2. The cDNA sequence of mouse BMP-4 mRNA and the
hybridization sites of BMP-4 targeting molecular beacons (MB1–MB8).
The oligonucleotide sequences of the MBs are shown in Table 1.
Figure 3. Real-time PCR result of BMP-4 mRNA before and after viral
infection in HDF cells. The BMP-4 mRNA levels were normalized
against the 18S rRNA levels. Bar graph shows the upregulated BMP-4
mRNA levels divided by the level of uninfected control cells.
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cence signals were produced by MB2, MB3, MB4, MB5,
MB6 and MB7, while the same cells showed a high level
of GFP expression, indicating that these beacons have
limited or no accessibility to BMP-4 mRNA targets. Note
the punctate MB signal shown in Figure 4 (and Figures 5
and 6), which appears to be an indication of speciﬁc
subcellular localization of BMP-4 mRNA. The subcellular
localization of other mRNAs has been reported elsewhere
(6,24–26).
The observation shown in Figure 4 has signiﬁcant
implications. For example, MB2 and MB6 were designed
based on the validated siRNA sites; but these sites were
clearly not accessible to beacons, possibly due to the
diﬀerences between siRNAs and MBs in probe–target
hybridization process. For siRNAs, their hybridization
to target mRNA involves the RNA-induced silencing
complex (RISC), which may remove RNA-binding
proteins and unwind the secondary structure of mRNA,
thereby enabling the siRNAs to hybridize readily to the
target mRNA. However, there is no data to suggest a
similar protein complex that facilitates the hybridization
of a beacon to its mRNA target. Based on our limited
observation, the eﬀective sites for MBs to detect mRNA in
living cells may be diﬀerent from that of siRNA-binding
sites.
The fact that MB3, MB4, MB5 and MB7 showed very
low signal from probe–target hybridization is also note-
worthy. It is understood that randomly chosen target
sequences, although unique, may not be accessible in live-
cell mRNA detection using MBs, as demonstrated
by MB3 and MB5. In situ hybridization assays could
increase the accessibility of oligonucleotide probes to
target mRNA by employing high temperature and low salt
concentration to unfold the mRNA secondary structures
and remove the RNA-binding proteins. However, these
conditions cannot be used in live-cell imaging studies and
therefore, the FISH probe-binding site does not ensure
the accessibility of beacons, as is the case for MB4. It is
clear from Table 1 that the melting temperature for MB
and beacon/target hybrids is not a factor in the extent of
MB binding.
Interestingly, MB7 and MB8 showed very diﬀerent
signal levels (Figure 4), although both beacons were
designed based on antisense oligonucleotide probe-
binding sites. As shown in Figure 4, MB8, which was
Figure 4. Fluorescence signal from nine diﬀerent MBs targeting BMP-4 mRNA and from GFP HDF cells 2 days after adenovirus infection. Left and
right panels display respectively the epiﬂuorescence images of GFP expression and signal from MBs targeting BMP-4 mRNA in the same cell. The
same exposure times were used for GFP and MB imaging. The results showed clearly that only MB1 and MB8 gave high signal level, indicating good
target accessibility, whereas all other MBs (MB2–MB7) have poor target accessibility, as indicated by the very weak signal levels.
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mRNA near the stop codon, exhibited very high ﬂuore-
scence signals in cells that expressed high levels of GFP,
whereas cells having MB7 did not show much signal from
BMP-4 mRNA targeting (even though they had high GFP
signal). This indicates that an antisense oligonucleotide
probe-binding site may or may not be accessible for MBs
in living cells.
Signal specificity
Another important issue in live-cell mRNA detection is
signal speciﬁcity. To determine whether the ﬂuorescence
signal from cells containing MB1 or MB8 is speciﬁc, we
performed several control studies. We ﬁrst ruled out the
possibility of high background signal due to nonspeciﬁc
interaction and/or probe degradation by endonucleases
in living cells. If the high ﬂuorescence signal from MB1
and MB8 were due to these false-positive events,
then other beacon designs (MB2–MB7) would show
similar levels of signal, which clearly is not the case
(Figure 4). To drive this point home, we delivered
random-sequence MBs (random beacons) into infected
cells and observed very weak signal level (data not shown),
conﬁrming the signal speciﬁcity of MB1 and MB8, since
random beacons do not have any complementary mRNA
target in human and mouse cells, and therefore the very
weak signal from random beacons indicates a low level of
probe degradation and nonspeciﬁc interaction in live
HDF cells. We also delivered MB1 and MB8 respectively
into cells without viral infection and found that very weak
ﬂuorescence signal was emitted from the MBs (data not
shown), again indicating signal speciﬁcity, since these cells
do not express mouse BMP-4 mRNA.
To further conﬁrm the signal speciﬁcity of MB1 and
MB8, we performed two additional experiments, one
using blocking RNA and the other siRNA, combined with
adenovirus infection. The blocking RNA approach is
similar to the use of blocking peptides (that mimic the
antigen-binding site of an antibody) to prevent the binding
between antigen and antibody in determining the speciﬁ-
city of an antibody. Speciﬁcally, blocking RNAs of
20mer (50-CAUAUAAUAACAGUCCAUGA-30) and
21mer (50-CCCCUCUACCACCAUCUCCUG-30) were
designed to hybridize to the same targeting sequences
of MB1 and MB8, respectively, thus competing with MB1
and MB8 for binding to BMP-4 mRNA. For each beacon,
we ﬁrst delivered blocking RNAs with 0.2–40-mM
concentration, then the corresponding MBs with 100-nM
concentration into infected cells that have upregulated
BMP-4 expression. Infected cells without blocking
RNAs were used as a control for each MB (MB1 and
MB8) in detecting BMP-4 mRNA.
As shown in Figure 5, cells incubated with blocking
RNAs prior to beacon delivery exhibited reduced intensity
of ﬂuorescence signal (Figure 5B andD) compared with
cells without blocking RNAs (Figure 5A and C), although
these cells showed the same level of GFP intensity
(an indication of having roughly the same level of BMP-
4 mRNA level). This result suggests that MB1 and MB8
have good target speciﬁcity to BMP-4 mRNA, since the
blocking RNAs appeared to reduce the amount of MBs
binding to BMP-4 mRNA. We observed that the blocking
eﬀect was small when low concentrations (<10mM) of
blocking RNAs were used (data not shown). This is likely
due to the diﬀerence in hybridization kinetics compared to
MBs, and the fact that short blocking RNAs can be
readily degraded in living cells.
As yet another conﬁrmation of signal speciﬁcity, we
used the speciﬁc siRNA to downregulate the expression of
BMP-4, and visualized the BMP-4 mRNA level using
MB1 and MB8. As a control, nonsilencing siRNA was
delivered into cells to conﬁrm that RNA-interference
induced BMP-4 knockdown was not due to nonspeciﬁc
oligonucleotides. Speciﬁcally, MB1 and MB8 were respec-
tively delivered into HDF cells containing either nonsilen-
cing or BMP-4 siRNA 2 days after siRNA transfection
and viral infection, and the resulting ﬂuorescence signal
was visualized using an epiﬂuorescence microscope.
Real-time PCR analysis of BMP-4 mRNA level was
Figure 5. Evaluation of the speciﬁcity of MB1 and MB8 in targeting
BMP-4 using blocking RNAs. Left and right panels display the
epiﬂuorescence images of GFP expression and MB signal respectively in
the same cells. Two hours after delivery of 40mM blocking RNAs into
infected HDF cells, 0.2mM of MB1 (A, B) and MB8 (C, D) were
delivered into HDF cells with and without blocking RNAs. For
comparison, images in (A, C) and (B, D) show respectively ﬂuorescence
signal in HDF cells without and with blocking RNAs, indicating a
reduced level of MB signal due to blocking, whereas the GFP signal
remained the same.
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following siRNA transfection and BMP-4 adenovirus
infection. The RT–PCR result shown in Figure 6A
indicates that the siRNA knocked down 90% of BMP-4
mRNA compared to that of control cells (cells with
nonsilencing siRNA). In the imaging studies of siRNA
knockdown, we again used GFP level as an independent
indicator, since the adenovirus encodes BMP-4 and GFP
Figure 6. The eﬀect of siRNA knockdown in conforming the speciﬁcity of MB1 (B, C) and MB8 (D, E). HDF cells with upregulated BMP-4 level
were transfected with either nonsilencing siRNA or BMP-4 siRNA 4h before adenovirus infection. (A) The eﬀect of siRNA in knocking down BMP-
4 mRNA level as measured by RT–PCR. The bar graph shows an  90% knockdown in the BMP-4 mRNA level as compared with that of control
cells transfected with nonsilencing siRNA. The BMP-4 mRNA levels were normalized by the 18S rRNA level. (B, D) Images of GFP (left panel) and
BMP-4-targeting molecular beacon (right panel) signals in control cells transfected with 100nM of nonsilencing siRNA followed by adenovirus
infection. The signal levels of MB1 (B) and MB8 (D) in the control cells corresponded well with the GFP intensity. (C, E) Images of GFP (left panel)
and BMP-4-targeting molecular beacon (right panel) signals in cells transfected with 100nM of BMP-4 siRNA followed by adenovirus infection. The
same exposure times for imaging GFP and MB signals were used for all the experiments. Regardless of the GFP signal level, ﬂuorescence signals
from MB1 (C) and MB8 (E) almost diminished completely as a result of siRNA knockdown, indicating excellent beacon signal speciﬁcity. (F) Real-
time PCR analysis suggesting that there is no antisense eﬀect of BMP-4 targeting molecular beacons (MB1 and MB8) in live HDF cells. Cells were
infected with virus for 2 days and then delivered with 1mM of MB1 and MB8, respectively. Twenty-four hours after delivery, RNA was isolated from
the cells. Bar graph shows the BMP-4 mRNA levels divided by that of control cells without any MB.
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expected to knock down BMP-4 without aﬀecting GFP
levels in the virus-infected cells.
As can be seen from Figure 6B, with nonsilencing
siRNA, the ﬂuorescence signal from MB1 was quite high,
consistent with the GFP ﬂuorescence signal level. When
siRNA was used, the ﬂuorescence signal from MB1 was
deceased signiﬁcantly (Figure 6C), although the GFP
signal remained high, reﬂecting the knockdown eﬀect of
siRNA. Similarly, with nonsilencing siRNA, the GFP
signal correlated well with BMP-4 mRNA levels detected
by MB8 (Figure 6D). However, transfection of BMP-4
siRNA diminished most of the ﬂuorescence signals from
MB8, while GFP signals from the same cells were high
(Figure 6E). The results in Figure 6 strongly suggest that
the signals from MB1 and MB8 are very speciﬁc in
detecting BMP-4 mRNAs in live HDF cells.
We next determined whether the BMP-4 targeting MBs
would induce BMP-4 mRNA degradation like the
siRNAs. It is well established that antisense oligonucleo-
tides with DNA backbone may induce RNase H activity
to degrade target mRNA in the DNA–RNA duplex by
hydrolysis (27). To determine if the reduced level of BMP-
4 mRNA in the siRNA experiment was due to unwanted
cleavage of BMP-4 mRNAs triggered by the beacons
rather than siRNA, RT–PCR assays was performed to
quantify the BMP-4 mRNA level using RNA samples
isolated from cells that were incubated with 1mM of MB1
or MB8 2 days after infection. As shown in Figure 6F,
BMP-4 mRNA levels maintained the same even when
cells contained MBs (MB1 or MB8). These results indicate
that the MB did not induce antisense eﬀects on target
mRNAs, therefore the reduction in beacon signal shown
in Figure 6C and E were entirely due to siRNA.
As the ﬁnal check of signal speciﬁcity, we carried out a
FISH assay to visualize the BMP-4 mRNA in ﬁxed
and permeabilized cells. Both control cells and cells with
upregulation of BMP-4 via adenovirus infection were
ﬁxed and incubated with the FISH probes that were
designed to hybridize with BMP-4 mRNA; the resulting
ﬂuorescence images are shown in Figure 7A and B for
control and infected cells, respectively. We found that only
cells with high GFP signals exhibited high ﬂuorescence
signal from the FISH probes; control cells showed very
low ﬂuorescence signal, as expected. The localization
pattern of BMP-4 mRNA in ﬁxed cells was essentially the
same as that in live cells. The only discernible diﬀerence
observed in the FISH assay was that MB signals
from BMP-4 mRNA were dispersed instead of punctated
in the perinuclear region seen in living cell assays. This
diﬀerence can be attributed to changes in cell structure
and mRNAs localization (28) due to the ﬁxation process.
Nevertheless, in situ hybridization of BMP-4 mRNA with
ﬂuorescent probes conﬁrmed the results of BMP-4 mRNA
detection in live cells.
Target sequence sensitivity
Taken together, the results shown in Figures 4–6 indicated
that, of the eight MBs designed to target BMP-4 mRNA
(Table 1), MB1 and MB8 produced robust and speciﬁc
signal above background, suggesting that the BMP-4
sequences targeted by MB1 and MB8 are structurally
accessible. Other beacons (MB2–MB7) that designed to
target diﬀerent sites on BMP-4 mRNA all gave a very
low level of ﬂuorescence signal, suggesting that these
sites are not readily accessible. This is most likely due
to the secondary structure of BMP-4 mRNA and the
RNA-binding proteins that occupy the speciﬁc sequences
targeted by MB2-MB7. It is not clear if there is a large
segment on the BMP-4 mRNA that has probe accessi-
bility, or there is only a ‘narrow’ region where MB could
hybridize to the target mRNA.
To address this issue, we evaluated the accessibility of
MBs that target sequences adjacent to MB8-targeting
sequence on BMP-4 mRNA. As shown in Figure 8A
(also Table 1), two MBs, MB8a and MB8b, were designed
so that their target sequences share respectively 8 and
10 overlapping bases with the target sequence of MB8.
Speciﬁcally, MB8a has 8 of its 17-base sequence over-
lapping with the 50 end of the MB8 sequence, and
MB8b has 10 of its 14-base sequence overlapping with
the 30 end of the MB8-targting sequence (Figure 8A).
As shown in Figure 8C and D, MB8a and MB8b produced
much lower ﬂuorescence signal compared with that
of MB8 (Figure 8B), although the GFP signal remained
the same. This result further demonstrates that the
ﬂuorescence signal from MB8 was critically dependent
on the speciﬁc target sequences; any change to the target
sequence, even a few bases, could signiﬁcantly reduce the
target accessibility. Therefore, MBs need to be designed
properly with very speciﬁc sequences in order to have
good target accessibility in live-cell mRNA detection.
Working toward beacon design rules
The ability to perform sensitive live-cell RNA detection is
important for biological studies of mRNA expression,
localization and transport, and for clinical studies such
as disease detection and diagnosis. Although FISH
Figure 7. BMP-4 mRNA detection using FISH probes in HDF cells.
FISH analysis of BMP-4 mRNA in cells without (A) and with (B) viral
infection induced upregulation. Only cells with GFP expression showed
an increased ﬂuorescence signal from BMP-4 FISH probe. Control cells
without infection showed very low ﬂuorescence signal level, consistent
with the low endogenous expression level of BMP-4 in HDF.
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in intact cells, it cannot be applied to track the dynamics
of changes in the amount and localization of mRNA in
living cells, and the ﬁxation and washing steps are not
only time consuming but prone to artifacts. Live-cell
visualization of mRNA using MBs has the potential to
address all these issues and provide a powerful tool for
gene expression dynamics studies. However, target acces-
sibility and signal speciﬁcity remain major challenges in
using MBs to detect endogenous mRNA in living cells.
As demonstrated in this study, due to the lack of target
accessibility, MBs designed to target a speciﬁc mRNA
(such as BMP-4 mRNA) may have very low signal,
rendering these MBs useless. Since MBs with 20-O-methyl
backbone have an increased aﬃnity to mRNAs compared
with DNA beacons (9), we tested if the use of 20-O-methyl
MBs could lead to better target accessibility. We
synthesized a beacon that has exactly the same design
as of MB6 but with 20-O-methyl backbone chemistry for
its loop sequence and targeted BMP-4 mRNA in infected
cells (with BMP-4 upregulation). However, we did not
see any signal increase compared with MB6 that used
DNA backbone, although the GFP level was very high
(data not shown). Therefore, 20-O-methyl modiﬁcation of
MBs may result in higher aﬃnity to target mRNA, but not
necessarily a better target accessibility.
A speciﬁc challenge is that accurate prediction of
the structure(s) of an mRNP in a living cell is very diﬃcult,
if not impossible, mainly due to the very limited biological
knowledge of RNA-binding proteins. As a result, no
computational models or general rules are available at the
present time to identify, at any stage of an mRNA, the
RNA-binding proteins bound, and the corresponding
binding sites. An alternative method is to identify acces-
sible sites on an mRNA at which MBs could hybridize and
give a high ﬂuorescence signal. As candidate sites, in this
study we tested siRNA-binding sites, antisense oligonu-
cleotide-binding sites, FISH probe-binding sites and other
sites that are located near the translation start codon or
termination codon regions. Interestingly, MBs (MB2 and
MB6) targeting siRNA-binding sites that have previously
been used to downregulate the BMP-4 mRNA level only
exhibited a weak ﬂuorescence signal compared with that
from MB1 and MB8.
To conﬁrm that MB hybridization and siRNA knock-
down do not correlate well, we designed two additional
siRNAs, siRNA-MB1 and siRNA-MB8, that target
the hybridization sites of MB1 and MB8, respectively.
The siRNA-MB1 and siRNA-MB8 were transfected using
thesame procedureaswithBMP-4siRNAandNS-siRNA,
followed by BMP-4 adenovirus infection. We found that
BMP-4 siRNA targeting the MB1 hybridization site only
gave a moderate knockdown eﬀect (44%), while siRNA
targeting the MB8 hybridization site exhibited a high
knockdown eﬀect (83%), comparable to the siRNA that
targets the BMP-4 mRNA sequence containing MB6
hybridization site (90%). Therefore, it appears that the
siRNA-binding sites are not necessarily accessible targets
for MB hybridization, and sites that are accessible for MB
hybridization in living cells are not necessarily good
siRNA-binding sites.
Among all the hybridization sites tested, we found that
sequences located near the start or termination codon are
more accessible for beacons to hybridize to its target
mRNA. Clearly, more experimental studies are required in
order to verify that the start or termination codon regions
are indeed accessible for a large group of mRNA
molecules. In our previous studies (6,9), we targeted
exon–exon junctions of Survivin and GAPDH genes and
found that they are accessible. Although more studies are
needed to conﬁrm that these are general design rules,
we believe the work performed in and insight gained from
the current study on MB design is the ﬁrst step toward the
development of robust beacon design rules.
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